Results 141 to 150 of about 4,979 (192)

Prokinetic agents and laryngopharyngeal reflux disease: Prokinetic agents and laryngopharyngeal reflux disease: A systematic review [PDF]

open access: yesLaryngoscope, 2014
ObjectivesOur objective was to systematically identify and evaluate prospective studies providing evidence for and against the use of prokinetic agents in the treatment of laryngopharyngeal reflux (LPR) disease.Data SourcesOur data sources were PubMed, Embase, BIOSIS, and Web of Science databases.Review MethodsA systematic literature review was ...
Thomas Carroll
exaly   +4 more sources

PROKINETIC AGENTS

Gastroenterology Clinics of North America, 1992
Prokinetic agents are medications that promote gastrointestinal motility. This article reflects the current state of our understanding of their mechanisms of action and their clinical utility in treating disorders of gastrointestinal motility, including gastroesophageal reflux, gastroparesis, small-intestinal dysmotility, and constipation.
Philip E Putnam
exaly   +3 more sources

Gastroesophageal Reflux and Prokinetic Agents [PDF]

open access: yesNeonatal Network, 2005
GASTROESOPHAGEAL REFLUX (GER), a common problem in preterm and term infants, occurs when there is retrograde movement of gastric contents into the esophagus. The severity of the reflux is related to the height of the gastric contents up into the esophagus or the oral pharynx. Transient lower esophageal sphincter relaxation is the main mechanism thought
Davita Hammer
openaire   +3 more sources

Prokinetic Agents: A Key in the Future of Gastroenterology

Gastroenterology Clinics of North America, 1989
Prokinetic drugs enhance the motility of the luminal organs of the gastrointestinal tract. Few drugs developed in this decade are likely to have a greater impact on the treatment of disorders of the gastrointestinal tract. Bethanechol and metaclopramide have proven the potential utility of this class of drugs, whereas newer agents promise to have both ...
exaly   +3 more sources

Recent Advances in Gastrointestinal Prokinetic Agents [PDF]

open access: yes, 2006
Publisher Summary This chapter discusses various gastrointestinal prokinetic agents, such as dopamine D 2 receptor antagonists, serotonin 5-hydroxytryptamine (5-HT 4 ) receptor agonists, serotonin 5-HT 3 receptor agonists, cholecystokinin CCK a receptor antagonists, motilin receptor agonists, and μ -opioid receptor antagonists.
David A. Sandham   +1 more
openaire   +2 more sources

Developments and Advances in Gastrointestinal Prokinetic Agents [PDF]

open access: yes, 2011
Publisher Summary This chapter highlights the advances made in the area of gastrointestinal (GI) prokinetics in both the clinical and early discovery phases between 2006 and 2010, with an emphasis on the more recent developments. The quality of life for people suffering from functional gastrointestinal disorders (FGIDs) is significantly reduced when ...
James W. Dale   +2 more
openaire   +2 more sources

Prokinetic agents in adult intensive care unit patients (PATIENCE)—An international inception cohort study protocol [PDF]

open access: yesActa Anaesthesiologica Scandinavica
Intensive care; Prokinetic agents; ProtocolCures intensives; Agents procinètics; ProtocolCuidados intensivos; Agentes procinéticos; ProtocoloBackground: Feeding intolerance is common in critically ill patients and can lead to malnutrition.
Anders Granholm   +2 more
exaly   +6 more sources

Home - About - Disclaimer - Privacy